CN108159152A - 一种纯酰素抗癌复合酶配方及其生产工艺 - Google Patents
一种纯酰素抗癌复合酶配方及其生产工艺 Download PDFInfo
- Publication number
- CN108159152A CN108159152A CN201710964817.4A CN201710964817A CN108159152A CN 108159152 A CN108159152 A CN 108159152A CN 201710964817 A CN201710964817 A CN 201710964817A CN 108159152 A CN108159152 A CN 108159152A
- Authority
- CN
- China
- Prior art keywords
- parts
- aloe
- rosa roxburghii
- roxburghii tratt
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000002252 acyl group Chemical group 0.000 title claims abstract description 24
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 24
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 18
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 8
- 150000001875 compounds Chemical class 0.000 title abstract description 3
- 238000009472 formulation Methods 0.000 title description 2
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 45
- 241001116389 Aloe Species 0.000 claims abstract description 44
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 17
- 235000019202 steviosides Nutrition 0.000 claims abstract description 15
- 240000002547 Rosa roxburghii Species 0.000 claims description 36
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 36
- 241001165494 Rhodiola Species 0.000 claims description 29
- 241000218231 Moraceae Species 0.000 claims description 26
- 239000012530 fluid Substances 0.000 claims description 25
- 239000007788 liquid Substances 0.000 claims description 25
- 239000004383 Steviol glycoside Substances 0.000 claims description 14
- 229930182488 steviol glycoside Natural products 0.000 claims description 14
- 235000019411 steviol glycoside Nutrition 0.000 claims description 14
- 150000008144 steviol glycosides Chemical class 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000005267 amalgamation Methods 0.000 claims description 10
- 238000003809 water extraction Methods 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 201000011510 cancer Diseases 0.000 abstract description 6
- 240000000249 Morus alba Species 0.000 abstract description 4
- 238000009825 accumulation Methods 0.000 abstract description 3
- 238000009792 diffusion process Methods 0.000 abstract description 3
- 230000007246 mechanism Effects 0.000 abstract description 2
- 244000042430 Rhodiola rosea Species 0.000 abstract 2
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract 2
- 241000220317 Rosa Species 0.000 abstract 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 abstract 1
- 229940013618 stevioside Drugs 0.000 abstract 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 3
- 229920000774 poly(2-methoxyaniline-5-sulfonic acid) polymer Polymers 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 241000220324 Pyrus Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 description 1
- 229960005327 acemannan Drugs 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000003822 cell turnover Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种纯酰素抗癌复合酶配方及其生产工艺，涉及生物技术领域。一种纯酰素抗癌复合酶配方所述配方包括以下原料（按重量分数）：芦荟20‑65份、刺梨10‑50份、桑葚5‑40份、红景天3‑25份、甜菊糖苷3‑15份。本发明提供的配方中包含芦荟、刺梨、桑葚、红景天四种原料，每一种原料都具有不同效果的抗癌功效，并且，每一种原料分别从不同的机理来达到抗癌的目的，使得本发明产品抗癌能力更加强大，能够有效地抵抗各种原因造成的癌细胞的生长积聚扩散。
Description
技术领域
本本发明涉及生物技术领域，尤其指一种纯酰素抗癌复合酶配方及其生产工艺。
背景技术
纯酰素（PMAS）是从芦荟多糖中提取的乙酰化甘露聚糖再纯化人体最易吸收的活细胞多糖物质精华，它选用原产于美国加勒比海库拉索群岛，后移植到中国海南有机种植的库拉索芦荟品种为原料，因为新近获得国际专利联盟的核准而闻名于世。活细胞纯酰素（PMAS）凭借优于动物活性肽抗衰老的逆生长年轻态功效以及抑制艾滋病病毒、抗肿瘤功效而备受医学界关注。活细胞纯酰素（PMAS）通过毛细血管迅速抵达人的皮下组织，刺激皮肤细胞的分裂，对于皮肤粗糙、暗晦、色斑、粉刺等都有很大的改善，使皮肤变得光滑、润泽并富有弹性，不过这种变化首先是基于人体机能的全面提高，使得细胞更新的速度加快，内分泌得到平衡、自身免疫力提高，新陈代谢旺盛。
芦荟(Aloe)是一种多年生百合科肉质的草本植物，是一种具有食用、美容、保健、医药以及观赏等功能的植物。芦荟化学成分复杂，已发现的成分超过160多种,主要有多糖、蒽醌类化合物、有机酸、氨基酸、酶和多肽、维生素、甾族化合物、矿物质、微量元素等有效活性成分。
现有技术中，有从芦荟中直接提取纯酰素然后加以利用的技术，但是对芦荟中纯酰素更加科学合理的利用还没有很好的办法。
发明内容
为了解决上述技术问题，本发明提供一种纯酰素抗癌复合酶配方及其生产工艺，用以解决现有技术中对于芦荟中纯酰素利用不够科学合理的问题。
本发明解决其技术问题所采用的的技术方案是：
一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟20-65份、刺梨10-50份、桑葚5-40份、红景天3-25份、甜菊糖苷3-15份。
优选的，一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟30-55份、刺梨15-45份、桑葚10-30份、红景天5-20份、甜菊糖苷5-10份。
优选的，一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟45份、刺梨30份、桑葚15份、红景天10份、甜菊糖苷3份。
一种纯酰素抗癌复合酶的生产工艺，包含以下步骤：
（1）取配方量的芦荟和刺梨，刺梨去柄，洗净晾干备用，芦荟去根，只保留叶片，洗净晾干备用；
（2）将步骤（1）准备的芦荟和刺梨分别采用水提法进行有效成分提取，取提取液备用；
（3）将步骤（2）制备的芦荟提取液和刺梨提取液分别进行超滤，取得的截留液和通过液分别放置备用；
（4）将刺梨截留液和芦荟截留液混合均匀，加入总截留液总重量5%的海藻糖，充分搅拌，溶解，混合均匀，静置3小时，备用；
（5）将混合后的截留液和通过液再次混合均匀，制得合并液；
（6）取配方量的桑葚和红景天，洗净晾干，备用；
（7）将处理好的桑葚和红景天分别通过水提法制得提取液，将桑葚提取液和红景天提取液混合均匀后与合并液再次混合，加入配方量的甜菊糖苷，即可。
本发明的有益效果是：本发明利用芦荟中富含的纯酰素，调节人体的内分泌和代谢系统，使机体各方面更趋于平衡。有效恢复人体旺盛的精力和体力，改善性功能，缓解神经衰弱。修复损伤的细胞，使衰退的器官功能得到改善，增强免疫力，强化身体免疫系统。从而减缓人体自身抵抗癌细胞在人体内积聚的过程，进而提高人体抗癌的能力。同样的，刺梨中富含的超氧化物歧化酶，能够捕捉人体内的氧自由基，减轻体内细胞老化速度，减缓人体内代谢废物的积聚，营造良好的细胞生存环境，有效遏制正常细胞的癌变过程，同样能够很好地避免癌症的发生。
此外本发明配方中除去刺梨以及芦荟的抗癌的效用之外又添加了桑葚和红景天。桑椹味甘酸、性寒，入肺、肝、肾、大肠经具有补肝益肾、生津润肠、乌发明目、止渴解毒、养颜等功效适用于阴血不足、头晕目眩、盗汗及津伤口渴、消渴、肠燥便秘等症。桑椹中所含的芸香苷、花色素、葡萄糖、果糖、苹果酸、钙质、无机盐、胡萝卜素、多种维生素及烟酸等成分，都有预防肿瘤细胞扩散，避免癌症发生的功效。现代医学研究证明，红景天中含有35种微量元素，18种氨基酸，维生素A、D、E和抗衰老活性超氧化物，其营养成分齐全且配伍合理，在目前所发现的植物中是罕见的。在药理学方面，现已证明红景天有中枢兴奋作用及“适应原样”效应，能消除人“累”，加强记忆力和注意力，使加快收缩频率的心脏恢复正常。红景天所含有效成分具有强心镇静、调节新陈代谢、调节神经系统和内分泌系统双向调节血糖、血压的作用，用于治疗脑血管疾病，老年性心肌能衰竭、糖尿病、低血压等症，也用于病后体虚、年老体弱、神经乏力等。
本发明提供的配方中包含芦荟、刺梨、桑葚、红景天四种原料，每一种原料都具有不同效果的抗癌功效，并且，每一种原料分别从不同的机理来达到抗癌的目的，使得本发明产品抗癌能力更加强大，能够有效地抵抗各种原因造成的癌细胞的生长积聚扩散。
具体实施方式
下面结合具体实施例对本发明作进一步说明：
实施例一
一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟20份、刺梨10份、桑葚5份、红景天3份、甜菊糖苷3份。
（1）取配方量的芦荟和刺梨，刺梨去柄，洗净晾干备用，芦荟去根，只保留叶片，洗净晾干备用；
（2）将步骤（1）准备的芦荟和刺梨分别采用水提法进行有效成分提取，取提取液备用；
（3）将步骤（2）制备的芦荟提取液和刺梨提取液分别进行超滤，取得的截留液和通过液分别放置备用；
（4）将刺梨截留液和芦荟截留液混合均匀，加入总截留液总重量5%的海藻糖，充分搅拌，溶解，混合均匀，静置3小时，备用；
（5）将混合后的截留液和通过液再次混合均匀，制得合并液；
（6）取配方量的桑葚和红景天，洗净晾干，备用；
（7）将处理好的桑葚和红景天分别通过水提法制得提取液，将桑葚提取液和红景天提取液混合均匀后与合并液再次混合，加入配方量的甜菊糖苷，即可。
实施例二
一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟65份、刺梨50份、桑葚40份、红景天25份、甜菊糖苷15份。
（1）取配方量的芦荟和刺梨，刺梨去柄，洗净晾干备用，芦荟去根，只保留叶片，洗净晾干备用；
（2）将步骤（1）准备的芦荟和刺梨分别采用水提法进行有效成分提取，取提取液备用；
（3）将步骤（2）制备的芦荟提取液和刺梨提取液分别进行超滤，取得的截留液和通过液分别放置备用；
（4）将刺梨截留液和芦荟截留液混合均匀，加入总截留液总重量5%的海藻糖，充分搅拌，溶解，混合均匀，静置3小时，备用；
（5）将混合后的截留液和通过液再次混合均匀，制得合并液；
（6）取配方量的桑葚和红景天，洗净晾干，备用；
（7）将处理好的桑葚和红景天分别通过水提法制得提取液，将桑葚提取液和红景天提取液混合均匀后与合并液再次混合，加入配方量的甜菊糖苷，即可。
实施例三
一种纯酰素抗癌复合酶配方，所述配方包括以下原料（按重量分数）：芦荟30份，刺梨30份，桑葚22份，红景天22份，甜菊糖苷9份。
（1）取配方量的芦荟和刺梨，刺梨去柄，洗净晾干备用，芦荟去根，只保留叶片，洗净晾干备用；
（2）将步骤（1）准备的芦荟和刺梨分别采用水提法进行有效成分提取，取提取液备用；
（3）将步骤（2）制备的芦荟提取液和刺梨提取液分别进行超滤，取得的截留液和通过液分别放置备用；
（4）将刺梨截留液和芦荟截留液混合均匀，加入总截留液总重量5%的海藻糖，充分搅拌，溶解，混合均匀，静置3小时，备用；
（5）将混合后的截留液和通过液再次混合均匀，制得合并液；
（6）取配方量的桑葚和红景天，洗净晾干，备用；
（7）将处理好的桑葚和红景天分别通过水提法制得提取液，将桑葚提取液和红景天提取液混合均匀后与合并液再次混合，加入配方量的甜菊糖苷，即可。
最后需要说明的是，具体实施方式是对本发明的进一步说明而非限制，对本领域普通技术人员来说，可以在不脱离本发明实质内容的情况下做进一步变换，而所有这些变换都应属于本发明所附权利要求的保护范围。
Claims (4)
1.一种纯酰素抗癌复合酶配方，其特征在于：所述配方包括以下原料（按重量分数）：芦荟20-65份、刺梨10-50份、桑葚5-40份、红景天3-25份、甜菊糖苷3-15份。
2.根据权利要求1所述的一种纯酰素抗癌复合酶配方，其特征在于：所述配方包括以下原料（按重量分数）：芦荟30-55份、刺梨15-45份、桑葚10-30份、红景天5-20份、甜菊糖苷5-10份。
3.根据权利要求1所述的一种纯酰素抗癌复合酶配方，其特征在于：所述配方包括以下原料（按重量分数）：芦荟45份、刺梨30份、桑葚15份、红景天10份、甜菊糖苷3份。
4.一种纯酰素抗癌复合酶的生产工艺，其特征在于：所述制备方法包含以下步骤：
(1)取配方量的芦荟和刺梨，刺梨去柄，洗净晾干备用，芦荟去根，只保留叶片，洗净晾干备用；
(2)将步骤（1）准备的芦荟和刺梨分别采用水提法进行有效成分提取，取提取液备用；
(3)将步骤（2）制备的芦荟提取液和刺梨提取液分别进行超滤，取得的截留液和通过液分别放置备用；
(4)将刺梨截留液和芦荟截留液混合均匀，加入总截留液总重量5%的海藻糖，充分搅拌，溶解，混合均匀，静置3小时，备用；
(5)将混合后的截留液和通过液再次混合均匀，制得合并液；
(6)取配方量的桑葚和红景天，洗净晾干，备用；
(7)将处理好的桑葚和红景天分别通过水提法制得提取液，将桑葚提取液和红景天提取液混合均匀后与合并液再次混合，加入配方量的甜菊糖苷，即可。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710964817.4A CN108159152A (zh) | 2017-10-17 | 2017-10-17 | 一种纯酰素抗癌复合酶配方及其生产工艺 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710964817.4A CN108159152A (zh) | 2017-10-17 | 2017-10-17 | 一种纯酰素抗癌复合酶配方及其生产工艺 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108159152A true CN108159152A (zh) | 2018-06-15 |
Family
ID=62526734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710964817.4A Pending CN108159152A (zh) | 2017-10-17 | 2017-10-17 | 一种纯酰素抗癌复合酶配方及其生产工艺 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108159152A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349612A (zh) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | 一种纯酰素抗癌复合酶配方 |
-
2017
- 2017-10-17 CN CN201710964817.4A patent/CN108159152A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109349612A (zh) * | 2018-11-29 | 2019-02-19 | 徐州市迪港商贸有限公司 | 一种纯酰素抗癌复合酶配方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107616956A (zh) | 一种芦荟护肤组合物及其制备方法 | |
| CN104686883A (zh) | 一种保肝护肝、增强人体免疫力的蜂花粉及其制备方法 | |
| KR100806125B1 (ko) | 탈모 방지 보조용 화장품 샴푸 제조방법 및 샴푸 | |
| KR101274778B1 (ko) | 천연 식물 추출물을 함유하는 기능성 화장료 조성물 | |
| CN112972354A (zh) | 一种护肤组合物及其在化妆品中的应用 | |
| CN101862446A (zh) | Sod葡萄保健酒 | |
| CN103301321B (zh) | 一种溶栓活性多糖合剂的制作工艺 | |
| CN105125467A (zh) | 一种祛红血丝乳液及其制备方法 | |
| KR20130026127A (ko) | 두피영양제조성물 및 그 제조방법 | |
| CN108159152A (zh) | 一种纯酰素抗癌复合酶配方及其生产工艺 | |
| KR101114399B1 (ko) | 두피영양제조성물 및 그 제조방법 | |
| CN104414954A (zh) | 蜗牛调敏霜 | |
| CN106857976A (zh) | 一种宣木瓜姜茶及其制备方法 | |
| CN108113921A (zh) | 一种纯酰素祛斑美肤复合酶配方及其生产工艺 | |
| CN104686884A (zh) | 一种含玉米低聚肽的蜂花粉及其制备方法 | |
| CN103877002A (zh) | 酵素酶蛋白排毒祛斑霜 | |
| CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
| CN106420483A (zh) | 一种净透黑头溶出液 | |
| CN106109288A (zh) | 一种铁皮石斛爽肤水及其制备方法 | |
| CN105410555A (zh) | 西柚酵素营养液及其制备方法 | |
| CN105878152A (zh) | 一种含有石榴果提取物的膏状浴盐 | |
| CN105326754B (zh) | 无添加剂食品级绿豆祛痘养护面膜及其绿色生产方法 | |
| CN105326755B (zh) | 无添加剂绿豆祛痘养护面膜纸及其绿色生产方法 | |
| CN107510708A (zh) | 一种马齿苋蒲公英袪疹膏及用法食品药膏日化品理疗膏 | |
| CN106821861A (zh) | 酵素酶蛋白排毒养颜祛斑霜 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |